KR102654800B1 - Composition of in vitro fertilization and in vitro culture medium for aged oocyte containing lipoic acid and resveratrol - Google Patents

Composition of in vitro fertilization and in vitro culture medium for aged oocyte containing lipoic acid and resveratrol Download PDF

Info

Publication number
KR102654800B1
KR102654800B1 KR1020230165561A KR20230165561A KR102654800B1 KR 102654800 B1 KR102654800 B1 KR 102654800B1 KR 1020230165561 A KR1020230165561 A KR 1020230165561A KR 20230165561 A KR20230165561 A KR 20230165561A KR 102654800 B1 KR102654800 B1 KR 102654800B1
Authority
KR
South Korea
Prior art keywords
vitro
resveratrol
mrc
medium
lipoic acid
Prior art date
Application number
KR1020230165561A
Other languages
Korean (ko)
Inventor
윤정
전경미
Original Assignee
의료법인마리아의료재단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 의료법인마리아의료재단 filed Critical 의료법인마리아의료재단
Priority to KR1020230165561A priority Critical patent/KR102654800B1/en
Application granted granted Critical
Publication of KR102654800B1 publication Critical patent/KR102654800B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0608Germ cells
    • C12N5/0609Oocytes, oogonia
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M21/00Bioreactors or fermenters specially adapted for specific uses
    • C12M21/06Bioreactors or fermenters specially adapted for specific uses for in vitro fertilization
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0608Germ cells
    • C12N5/061Sperm cells, spermatogonia
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/42Organic phosphate, e.g. beta glycerophosphate
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/999Small molecules not provided for elsewhere

Abstract

본 발명은 리포산 및 레스베라트롤을 포함하는 노화된 난자의 체외수정 및 체외배양용 배지 조성물에 관한 것으로, 구체적으로 리포산(lipoic acid) 및 레스베라트롤(resveratrol), 또는 추가로 인산염(phosphate)을 포함하는 배지를 노화된 난자 체외수정 및 체외배양에 이용하면, 배아의 분열 및 배반포 형성률이 증가하고, 배아의 질이 향상되어 임신률 및 착상률이 증가하는 것을 확인하였으므로, 상기 배지는 노화된 난자의 체외수정 및 체외배양용 배지 조성물로 적합하고, 궁극적으로 체외배양 배아의 품질을 향상시켜 임신률 및 착상률에 기여할 수 있다.The present invention relates to a medium composition for in vitro fertilization and in vitro culture of aged eggs containing lipoic acid and resveratrol, and specifically to a medium containing lipoic acid and resveratrol, or additionally phosphate. When used for in vitro fertilization and in vitro culture of aged eggs, it was confirmed that the rate of embryo division and blastocyst formation increased, and the quality of the embryo was improved, increasing the pregnancy rate and implantation rate. Therefore, the above medium was used for in vitro fertilization and in vitro culture of aged eggs. It is suitable as a culture medium composition and can ultimately improve the quality of in vitro cultured embryos, contributing to pregnancy and implantation rates.

Description

리포산 및 레스베라트롤을 포함하는 노화된 난자의 체외수정 및 체외배양용 배지 조성물{Composition of in vitro fertilization and in vitro culture medium for aged oocyte containing lipoic acid and resveratrol}{Composition of in vitro fertilization and in vitro culture medium for aged oocyte containing lipoic acid and resveratrol}

본 발명은 리포산(lipoic acid) 및 레스베라트롤(resveratrol)을 포함하는 노화된 난자의 체외수정 및 체외배양용 배지 조성물에 관한 것으로, 보다 상세하게는 리포산 및 레스베라트롤을 유효성분으로 포함하는 노화된 난자 및 정자의 체외수정 및 체외배양용 배지 조성물에 관한 것이다.The present invention relates to a medium composition for in vitro fertilization and in vitro culture of aged eggs containing lipoic acid and resveratrol, and more specifically to aged eggs and sperm containing lipoic acid and resveratrol as active ingredients. It relates to a medium composition for in vitro fertilization and in vitro culture.

동물 산업의 증진과 인간의 불임(infertility) 또는 난임(subfertility)의 치료를 위해 체외수정을 포함한 배아의 체외생산과 같은 다양한 보조적 번식 기술 방법(assisted reproductive technology)이 이행되고 있다. 특히, 최근 초혼 연령 증가 및 출산 연령의 노령화 등으로 인해 임신 시도 연령이 높아지면서 난임 환자 수가 매년 증가하고 있는 상황에서, 체외에서 채취된 난자를 정자로 수정시킨 후 수정된 배아만을 체외에서 배양하여 여성의 자궁 내에 이식하는 시험관아기시술은 난임을 극복하기 위한 가장 보편적인 시술방법이다. 그러나, 고령 난임 환자의 난자는 노화되어 미토콘드리아의 기능이 저하되고 활성산소 발생이 많아 난자의 질이 떨어지고 임신이 잘 되지 않는다. Various assisted reproductive technologies, such as in vitro production of embryos, including in vitro fertilization, are being implemented to promote the animal industry and to treat infertility or subfertility in humans. In particular, in a situation where the number of infertility patients is increasing every year as the age at conception increases due to the recent increase in age at first marriage and aging of childbirth, etc., eggs collected from outside the body are fertilized with sperm, and only the fertilized embryos are cultured outside the body to make the woman pregnant. In vitro fertilization (IVF) implantation within the uterus is the most common treatment method to overcome infertility. However, as the eggs of elderly infertility patients age, their mitochondrial function deteriorates and the production of oxygen radicals increases, resulting in poor egg quality and poor pregnancy outcomes.

배아의 체외생산은 체내에서 일어나는 난자의 성숙, 수정 및 배아 발달의 일련의 과정을 체외에서 실시하여 일정 수준 이상 발달이 진행된 배아를 확보하는 기술이다. 체외배양에서 배양 환경에 따라 생산 효율의 차이가 나타나게 되고, 체외배양을 통한 배아 및 배반포의 생성 효율 향상은 착상 및 임신율의 증가로 이어지는바, 체외생산 기술 적용 시 배아의 질을 향상시켜 배아의 생성 효율을 높일 수 있는 적합한 배양액을 개발하는 것이 필요하다.In vitro production of embryos is a technology that secures embryos that have developed beyond a certain level by carrying out the series of processes of egg maturation, fertilization, and embryo development that occur inside the body outside the body. In in vitro culture, differences in production efficiency appear depending on the culture environment, and the improvement in the production efficiency of embryos and blastocysts through in vitro culture leads to an increase in implantation and pregnancy rates. When applying in vitro production technology, the quality of embryos is improved to produce embryos. It is necessary to develop a suitable culture medium that can increase efficiency.

한편, 레스베라트롤(resveratrol)은 스틸벤(stilbene)의 한 종류로서, 오디, 땅콩, 포도, 라스베리, 크렌베리 등의 베리류 등을 포함한 많은 식물에서 발견되고 있다. 레스베라트롤은 항암 및 강력한 항산화 작용을 하는 것으로 알려져 있다.Meanwhile, resveratrol is a type of stilbene and is found in many plants, including berries such as mulberries, peanuts, grapes, raspberries, and cranberries. Resveratrol is known to have anticancer and powerful antioxidant properties.

리포산(lipoic acid)은 알파-리포산으로도 불리며, 미토콘드리아에서 에너지 생성 과정에서 사용되는 화합물 중 하나로, 최근 건강식품 및 멀티 비타민의 한 성분으로서 사용되고 있다. Lipoic acid, also called alpha-lipoic acid, is one of the compounds used in the energy production process in mitochondria, and has recently been used as an ingredient in health foods and multivitamins.

이에, 본 발명자들은 노화된 난자 체외수정 및 체외배양에 적합한 배지 조성물을 개발하기 위해 노력한 결과, 리포산 및 레스베라트롤, 또는 추가로 인산염(phosphate)을 포함하는 배지를 고령 마우스 모델 및 고령 난임 환자의 난자 체외수정 및 체외배양에 이용하면 배아의 분열 및 배반포 형성률이 증가하고, 배아의 질이 향상되어 임신률 및 착상률이 증가하는 것을 확인하였다. 따라서, 본 발명자들은 상기 리포산 및 레스베라트롤, 또는 리포산, 레스베라트롤 및 인산염이 노화된 난자의 체외수정 및 체외배양용 배지 조성물의 유효성분으로 적합함을 밝힘으로써, 본 출원에 이르게 되었다.Accordingly, the present inventors made efforts to develop a medium composition suitable for in vitro fertilization and in vitro culture of aged oocytes, and as a result, a medium containing lipoic acid and resveratrol, or additional phosphate, was used for in vitro fertilization of oocytes from aged mouse models and elderly infertility patients. It was confirmed that when used for fertilization and in vitro culture, the rate of embryo division and blastocyst formation increased, and the quality of the embryo improved, increasing the pregnancy rate and implantation rate. Accordingly, the present inventors have arrived at the present application by revealing that lipoic acid and resveratrol, or lipoic acid, resveratrol, and phosphate, are suitable as active ingredients in a medium composition for in vitro fertilization and in vitro culture of aged eggs.

대한민국 등록특허 제10-2054710호Republic of Korea Patent No. 10-2054710 대한민국 등록특허 제10-2469369호Republic of Korea Patent No. 10-2469369

본 발명의 목적은 노화된 난자의 질, 배아 발달률 등을 향상시킬 수 있는 체외수정 및 체외배양용 배지 조성물을 제공하는 것이다. The purpose of the present invention is to provide a medium composition for in vitro fertilization and in vitro culture that can improve the quality and embryo development rate of aged eggs.

본 발명의 목적을 달성하기 위하여, 본 발명은 리포산(lipoic acid) 및 레스베라트롤(resveratrol)을 포함하는 포유동물의 난자 및 정자 체외수정 및 체외배양용 배지 조성물을 제공한다.In order to achieve the object of the present invention, the present invention provides a medium composition for in vitro fertilization and in vitro culture of mammalian eggs and sperm containing lipoic acid and resveratrol.

또한, 본 발명은 상기 배지 조성물에 인산염(phosphate)을 추가로 포함하는 포유동물의 난자 및 정자 체외수정 및 체외배양용 배지 조성물을 제공한다.In addition, the present invention provides a medium composition for in vitro fertilization and in vitro culture of mammalian eggs and sperm, further comprising phosphate in the medium composition.

본 발명의 리포산(lipoic acid) 및 레스베라트롤(resveratrol), 또는 추가로 인산염(phosphate)을 포함하는 배지를 노화된 난자 체외수정 및 체외배양에 이용하면, 배아의 분열 및 배반포 형성률이 증가하고, 배아의 질이 향상되어 임신률 및 착상률이 증가하는 것을 확인하였으므로, 상기 배지는 노화된 난자의 체외수정 및 체외배양용 배지 조성물로 적합하고, 궁극적으로 체외배양 배아의 품질을 향상시켜 임신률 및 착상률에 기여할 수 있다.When the medium containing lipoic acid and resveratrol, or additionally phosphate, of the present invention is used for in vitro fertilization and in vitro culture of aged eggs, the rate of embryo division and blastocyst formation increases, and the embryo's Since it was confirmed that the pregnancy rate and implantation rate increased due to improved quality, the medium is suitable as a medium composition for in vitro fertilization and in vitro culture of aged eggs, and ultimately contributes to the pregnancy rate and implantation rate by improving the quality of in vitro cultured embryos. You can.

이하, 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.

본 발명은 리포산(lipoic acid) 및 레스베라트롤(resveratrol)을 유효성분으로 포함하는, 포유동물의 난자 및 정자 체외수정 및 체외배양용 배지 조성물을 제공한다.The present invention provides a medium composition for in vitro fertilization and in vitro culture of mammalian eggs and sperm, comprising lipoic acid and resveratrol as active ingredients.

본 발명에서, "체외수정(in vitro fertilization, IVF)"이란, 난자와 정자가 체내에서 수정하는 상태와 구분되는 방법으로, 실험실의 인큐베이터(incubator)에서 체내 자궁의 환경과 유사한 조건으로 수정·배양하는 일련의 실험실 과정을 의미하며, 본 발명의 배지 조성물은 이러한 체외수정, 구체적으로 노화된 난자와 정자의 체외수정에 최적화된 배지 조성물이다.In the present invention, “in vitro fertilization (IVF)” is a method that is distinguished from the state in which eggs and sperm are fertilized inside the body, and is fertilized and cultured in a laboratory incubator under conditions similar to the environment of the uterus in the body. It refers to a series of laboratory processes, and the medium composition of the present invention is a medium composition optimized for such in vitro fertilization, specifically, in vitro fertilization of aged eggs and sperm.

또한, "체외배양 (in vitro culture, IVC)"이란, 상기 체외수정 후 생성되는 수정란을 체외의 배지에서 배양하는 것으로, 수정란의 체외배양을 통해 배아 및 배반포를 형성시키는 과정을 의미하며, 본 발명의 배지 조성물은 이러한 체외배양, 구체적으로 노화된 난자와 정자의 체외수정 후 생성되는 수정란의 체외배양에 최적화된 배지 조성물이다.In addition, "in vitro culture (IVC)" refers to culturing the fertilized egg produced after the above in vitro fertilization in a medium outside the body, and refers to the process of forming embryos and blastocysts through in vitro culture of the fertilized egg, and the present invention The medium composition of is a medium composition optimized for such in vitro culture, specifically for the in vitro culture of fertilized eggs produced after in vitro fertilization of aged eggs and sperm.

본 발명에서, 상기 배지 조성물은 0.1 내지 2 μM의 리포산을 포함할 수 있고, 구체적으로 0.3 내지 1.5 μM의 리포산을 포함할 수 있으며, 보다 구체적으로 0.8 내지 1.2 μM의 리포산을 포함할 수 있으나, 이에 제한되지 않는다.In the present invention, the medium composition may contain 0.1 to 2 μM lipoic acid, specifically 0.3 to 1.5 μM lipoic acid, and more specifically 0.8 to 1.2 μM lipoic acid. Not limited.

본 발명에서, 상기 배지 조성물은 0.1 내지 1 μM의 레스베라트롤을 포함할 수 있고, 구체적으로 0.2 내지 0.8 μM의 레스베라트롤을 포함할 수 있으며, 보다 구체적으로 0.4 내지 0.6 μM의 레스베라트롤을 포함할 수 있으나, 이에 제한되지 않는다.In the present invention, the medium composition may contain 0.1 to 1 μM of resveratrol, specifically 0.2 to 0.8 μM of resveratrol, and more specifically 0.4 to 0.6 μM of resveratrol. Not limited.

본 발명에서, 상기 배지 조성물은 인산염을 추가로 포함할 수 있다. 이때 인산염은 0.1 내지 1 mM로 포함할 수 있고, 구체적으로 0.1 내지 0.7 mM로 포함할 수 있으며, 보다 구체적으로 0.1 내지 0.5 mM로 포함할 수 있으나, 이에 제한되지 않는다.In the present invention, the medium composition may additionally include phosphate. At this time, phosphate may be included at 0.1 to 1 mM, specifically 0.1 to 0.7 mM, and more specifically 0.1 to 0.5 mM, but is not limited thereto.

본 발명에서, 상기 배지 조성물은 체외배양 배지에 첨가될 수 있다. 상기 체외배양 배지는 탄소원, 아미노산, 각종 영양물질, 혈청, 성장인자, 무기염류 등 세포의 성장 및 증식 등에 필수적인 요소를 포함하여 생체 외에서 세포의 성장 및 증식을 가능케 하는 물질을 의미하며, 구체적으로 통상적인 포유동물의 체외수정 또는 체외수정된 수정란을 배양하기 위해 사용되는 기본배지를 제한 없이 이용할 수 있다. 상기 배지는 체외수정 또는 체외수정된 수정란의 종류에 따라 당업자가 공지된 배지를 적절하게 선택하여 사용할 수 있다. In the present invention, the medium composition can be added to the in vitro culture medium. The in vitro culture medium refers to a substance that enables the growth and proliferation of cells in vitro, including essential elements such as carbon sources, amino acids, various nutrients, serum, growth factors, and inorganic salts, and specifically, conventional The basic medium used for in vitro fertilization of mammals or for culturing in vitro fertilized eggs can be used without limitation. As for the medium, a person skilled in the art can appropriately select and use a known medium depending on the type of in vitro fertilization or in vitro fertilized egg.

상기 탄소원의 예로 글루코스, 피루부산나트륨(sodium pyruvate), 젖산칼슘(calcium lactate) 또는 젖산나트륨(sodium lactate)을 들 수 있으나, 이에 제한되지 않는다.Examples of the carbon source include, but are not limited to, glucose, sodium pyruvate, calcium lactate, or sodium lactate.

상기 무기염류의 예로 염화나트륨(NaCl), 염화칼륨(KCl) 또는 탄산수소나트륨(NaHCO3)을 들 수 있으나, 이에 제한되지 않는다.Examples of the inorganic salts include, but are not limited to, sodium chloride (NaCl), potassium chloride (KCl), or sodium hydrogen carbonate (NaHCO 3 ).

본 발명의 일 실시예에서는 체외배양 배지로 [표 1]의 조성을 갖는 MRC(Maria Research Center) 배지를 사용하였다.In one embodiment of the present invention, MRC (Maria Research Center) medium having the composition shown in [Table 1] was used as an in vitro culture medium.

본 발명에서, 상기 포유동물은 예를 들어, 인간, 돼지, 소, 염소, 양, 말과 같은 가축, 애완동물, 쥐, 기니피그 등과 같은 실험동물일 수 있으나, 이에 제한되지 않는다.In the present invention, the mammal may be, for example, a human, a livestock animal such as a pig, a cow, a goat, a sheep, a horse, a pet, a laboratory animal such as a rat, a guinea pig, etc., but is not limited thereto.

본 발명의 구체적인 실시예에서, 본 발명자들은 리포산 및 레스베라트롤을 포함하는 체외수정 및 체외배양용 배지, 및 추가로 인산염을 포함하는 체외수정 및 체외배양용 배지를 제조하였다.In a specific example of the present invention, the present inventors prepared a medium for in vitro fertilization and in vitro culture containing lipoic acid and resveratrol, and a medium for in vitro fertilization and in vitro culture further containing phosphate.

또한, 본 발명자들은 리포산 및 레스베라트롤을 포함하는 체외수정 및 체외배양용 배지를 이용하여 고령 마우스 모델에서 채취한 노화된 난자 및 정자의 체외수정을 유도하고, 체외수정된 수정란을 체외배양하는 경우 배아의 분열 및 배반포 형성률이 증가하는 것을 확인하였다.In addition, the present inventors used a medium for in vitro fertilization and in vitro culture containing lipoic acid and resveratrol to induce in vitro fertilization of aged eggs and sperm collected from an elderly mouse model, and when culturing the in vitro fertilized eggs in vitro, the embryo It was confirmed that the rate of division and blastocyst formation increased.

아울러, 본 발명자들은 리포산, 레스베라트롤 및 인산염을 포함하는 체외수정 및 체외배양용 배지를 이용하여 고령 난임 환자에서 채취한 난자 및 정자의 체외수정을 유도하고, 체외수정된 수정란을 체외배양하는 경우 배아의 질이 향상되어 임신률 및 착상률이 증가하는 것을 확인하였다.In addition, the present inventors induced in vitro fertilization of eggs and sperm collected from elderly infertile patients using a medium for in vitro fertilization and in vitro culture containing lipoic acid, resveratrol, and phosphate, and when culturing the in vitro fertilized eggs in vitro, the embryo It was confirmed that the quality improved and the pregnancy rate and implantation rate increased.

따라서, 본 발명의 리포산 및 레스베라트롤, 또는 추가로 인산염을 포함하는 체외수정 및 체외배양용 배지 조성물은 노화된 난자 체외수정 및 체외배양에 적합하고, 궁극적으로 체외배양 배아의 품질을 향상시켜 임신률 및 착상률에 기여할 수 있다.Therefore, the medium composition for in vitro fertilization and in vitro culture containing lipoic acid and resveratrol, or additionally phosphate, of the present invention is suitable for in vitro fertilization and in vitro culture of aged eggs, and ultimately improves the quality of in vitro cultured embryos, thereby increasing the pregnancy rate and May contribute to implantation rate.

또한, 본 발명은In addition, the present invention

1) 포유동물의 성숙된 난자를 준비하는 단계; 1) Preparing mature mammalian eggs;

2) 상기 단계 1)의 성숙된 난자와 정자를 본 발명에 따른 포유동물 난·정자 체외수정 및 수정란의 체외배양용 배지 조성물에 첨가하여 체외수정시키는 단계; 및2) in vitro fertilization by adding the mature eggs and sperm of step 1) to the medium composition for in vitro fertilization of mammalian eggs and sperm and in vitro culture of fertilized eggs according to the present invention; and

3) 상기 단계 2)에서 수정된 체외수정란을 상기 배지 조성물에서 배양하는 단계를 포함하는, 포유동물 체외수정란의 체외배양 방법을 제공한다.3) It provides a method of in vitro culturing of mammalian in vitro fertilized eggs, comprising the step of culturing the in vitro fertilized eggs fertilized in step 2) in the medium composition.

본 발명에서, 상기 단계 1)에서 포유동물의 성숙된 난자는 하기의 단계를 포함하는 방법에 의해 준비될 수 있으나, 이에 제한되지 않는다:In the present invention, the mammalian oocyte matured in step 1) may be prepared by a method comprising the following steps, but is not limited thereto:

a) 포유동물의 난자를 채취하는 단계; 및 a) collecting mammalian eggs; and

b) 상기 난자를 체외성숙시키는 단계.b) In vitro maturation of the egg.

본 발명에서, "체외성숙(in vitro maturation, IVM)"이란, 체외수정을 수행하기 전에 채취된 난모세포가 감수 분열을 수행하여 제 2 감수분열 중기(metaphase II)에 도달하도록 유도하는 방법을 의미한다. 상기 난모세포는 난원세포에서 분화되어 세포활성이 중지된 세포를 의미하고, 본 발명의 용어 "난자"는 상기 "난모세포"와 실질적으로 동일한 세포를 의미하는 것으로 간주될 수 있다. In the present invention, “in vitro maturation (IVM)” refers to a method of inducing oocytes collected before performing in vitro fertilization to perform meiosis and reach the second meiotic metaphase II. do. The oocyte refers to a cell that differentiates from an oval cell and ceases cellular activity, and the term “oocyte” in the present invention can be considered to mean a cell that is substantially the same as the “oocyte.”

본 발명의 체외수정 및 체외배양 방법은 노화된 난자의 배아 발달 능력을 향상시키는 리포산 및 레스베라트롤, 또는 추가로 인산염을 유효성분으로 포함하는 체외수정 및 체외배양용 배지 조성물을 사용함으로써, 배아의 질, 배아 분열 및 배반포 형성률을 향상시킬 수 있다.The in vitro fertilization and in vitro culture method of the present invention improves the quality of embryos, It can improve embryo division and blastocyst formation rates.

이하, 본 발명을 실시예 및 실험예에 의해 상세히 설명한다.Hereinafter, the present invention will be described in detail through examples and experimental examples.

단, 하기 실시예 및 실험예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기 실시예 및 실험예에 한정되는 것은 아니다.However, the following examples and experimental examples only illustrate the present invention, and the content of the present invention is not limited to the following examples and experimental examples.

<실시예 1> 리포산(lipoic acid) 및 레스베라트롤(resveratrol)이 첨가된 체외수정 및 체외배양용 배지의 제조<Example 1> Preparation of in vitro fertilization and in vitro culture medium containing lipoic acid and resveratrol

리포산(lipoic acid) 및 레스베라트롤(resveratrol)이 첨가된 체외수정 및 체외배양을 위한 배지는 하기 [표 1]의 조성을 갖는 MRC(Maria Research Center)#D01, MRC#D13 및 MRC#D46 배지 각각에 1 μM의 리포산(Sigma-Aldrich, USA) 및 0.5 μM의 레스베라트롤(Sigma-Aldrich, USA)을 첨가하여 제조하였다.The medium for in vitro fertilization and in vitro culture supplemented with lipoic acid and resveratrol is 1 each of MRC (Maria Research Center) #D01, MRC #D13, and MRC #D46 medium with the composition shown in Table 1 below. It was prepared by adding µM lipoic acid (Sigma-Aldrich, USA) and 0.5 µM resveratrol (Sigma-Aldrich, USA).

배지badge 구성composition MRC#D01MRC#D01 102.7 mM 염화나트륨(sodium chloride)102.7mM sodium chloride 0.58 mM 글루코스(glucose)0.58mM glucose 0.50 mM 알라닐-글루타민(alanyl-glutamine)0.50 mM alanyl-glutamine 0.50 mM 글리실-글루타민(glycyl-glutamine)0.50 mM glycyl-glutamine 10.50 mM 젖산나트륨(sodium lactate)10.50 mM sodium lactate 5.0 mg/mL 인간혈청알부민(human serum albumin)5.0 mg/mL human serum albumin 1.0 mg/mL 알파 및 베타 글로불린(alpha and beta globulins)1.0 mg/mL alpha and beta globulins MRC#D13MRC#D13 102.7 mM 염화나트륨(sodium chloride)102.7mM sodium chloride 0.58 mM 글루코스(glucose)0.58mM glucose 0.50 mM 알라닐-글루타민(alanyl-glutamine)0.50 mM alanyl-glutamine 0.50 mM 글리실-글루타민0.50 mM glycyl-glutamine 10.50 mM 젖산나트륨(sodium lactate)10.50 mM sodium lactate 0.10 mg/mL 히알루론산(hyaluronic acid)0.10 mg/mL hyaluronic acid 5.0 mg/mL 인간혈청알부민(human serum albumin)5.0 mg/mL human serum albumin 1.0 mg/mL 알파 및 베타 글로불린(alpha and beta globulins)1.0 mg/mL alpha and beta globulins MRC#D46MRC#D46 106.0 mM 염화나트륨(sodium chloride)106.0mM sodium chloride 3.15 mM 글루코스(glucose)3.15mM glucose 0.50 mM 알라닐-글루타민(alanyl-glutamine)0.50 mM alanyl-glutamine 0.50 mM 글리실-글루타민(glycyl-glutamine)0.50 mM glycyl-glutamine 5.87 mM 젖산나트륨(sodium lactate)5.87 mM sodium lactate 0.10 mg/mL 히알루론산(hyaluronic acid)0.10 mg/mL hyaluronic acid 5.0 mg/mL 인간혈청알부민(human serum albumin)5.0 mg/mL human serum albumin 1.0 mg/mL 알파 및 베타 글로불린(alpha and beta globulins)1.0 mg/mL alpha and beta globulins

<실시예 2> 리포산, 레스베라트롤 및 인산염(phosphate)이 첨가된 체외수정 및 체외배양용 배지의 제조<Example 2> Preparation of medium for in vitro fertilization and in vitro culture with lipoic acid, resveratrol and phosphate added

리포산, 레스베라트롤 및 인산염(phosphate)이 첨가된 체외수정 및 체외배양을 위한 배지는 MRC#D01, MRC#D13 및 MRC#D46 배지 각각에 1 μM의 리포산, 0.5 μM의 레스베라트롤 및 0.3 mM의 인산염(Sigma-Aldrich, USA)을 첨가하여 제조하였다.Media for in vitro fertilization and in vitro culture supplemented with lipoic acid, resveratrol, and phosphate are MRC#D01, MRC#D13, and MRC#D46 media, each containing 1 μM lipoic acid, 0.5 μM resveratrol, and 0.3 mM phosphate (Sigma -Aldrich, USA) was added to prepare it.

<비교예 1> 리포산이 첨가된 체외수정 및 체외배양용 배지의 제조<Comparative Example 1> Preparation of in vitro fertilization and in vitro culture medium containing lipoic acid

1 μM의 리포산만을 첨가하는 것을 제외하고 상기 <실시예 1>과 동일한 방법으로 리포산이 첨가된 체외수정 및 체외배양용 배지를 제조하였다.A medium for in vitro fertilization and in vitro culture to which lipoic acid was added was prepared in the same manner as <Example 1>, except that only 1 μM lipoic acid was added.

<비교예 2> 레스베라트롤이 첨가된 체외수정 및 체외배양용 배지의 제조<Comparative Example 2> Preparation of in vitro fertilization and in vitro culture medium containing resveratrol

0.5 μM의 레스베라트롤만을 첨가하는 것을 제외하고 상기 <실시예 1>과 동일한 방법으로 레스베라트롤이 첨가된 체외수정 및 체외배양용 배지를 제조하였다.A medium for in vitro fertilization and in vitro culture to which resveratrol was added was prepared in the same manner as in <Example 1> except that only 0.5 μM of resveratrol was added.

<비교예 3> 인산염이 첨가된 체외수정 및 체외배양용 배지의 제조<Comparative Example 3> Preparation of medium for in vitro fertilization and in vitro culture with added phosphate

0.3 mM의 인산염만을 첨가하는 것을 제외하고 상기 <실시예 1>과 동일한 방법으로 레스베라트롤이 첨가된 체외수정 및 체외배양용 배지를 제조하였다.A medium for in vitro fertilization and in vitro culture to which resveratrol was added was prepared in the same manner as in <Example 1> except that only 0.3 mM phosphate was added.

<실험예 1> 체외수정 및 체외배양 시 리포산 및 레스베라트롤 처리가 고령 마우스 모델의 난자의 배아 발달에 미치는 영향 확인<Experimental Example 1> Confirmation of the effect of lipoic acid and resveratrol treatment on embryonic development of eggs in an elderly mouse model during in vitro fertilization and in vitro culture

고령화에 따른 난자의 노화는 미토콘드리아의 기능 저하 및 활성산소 발생이 많아 난자의 질이 떨어지고 임신이 잘 안 되는 문제점이 있다. 이에, 본 발명의 체외수정 및 체외배양 배지가 노화된 난자 체외수정 및 체외배양에 적합한지 알아보기 위하여, 고령 마우스 모델의 난자를 상기 <실시예 1>에서 제조한 체외수정 및 체외배양 배지를 이용하여 체외수정 및 체외배양한 후 배아 발달능을 확인하였다.The aging of eggs due to aging causes problems such as decreased mitochondrial function and increased production of oxygen radicals, leading to poor egg quality and poor pregnancy. Therefore, in order to determine whether the in vitro fertilization and in vitro culture medium of the present invention is suitable for in vitro fertilization and in vitro culture of aged eggs, eggs from an aged mouse model were used using the in vitro fertilization and in vitro culture medium prepared in <Example 1> above. After in vitro fertilization and in vitro culture, the developmental capacity of the embryo was confirmed.

<1-1> 고령 마우스 모델로부터 노화된 난자 준비<1-1> Preparation of aged oocytes from aged mouse model

모든 동물 실험은 NIH 연구동물 관리 및 사용 안내에 준수하여 수행되었다. 동물 연구는 마리아의료재단 난임의학연구소의 동물 실험 윤리 위원회에서 승인되었다. 고령 마우스 모델로 62주 된 B6D2 F1(C57BL/6×DBA) 암컷 마우스를 이용하였다. 암컷 마우스에 성선자극호르몬(gonadotropin) 5 IU를 투여하고, 임신한 말의 혈청성선자극호르몬(pregnant mare serum gonadotropin, PMSG; Folligon, Intervet, UK)을 복강내 주사한 후 48시간 후에 사람의 융모막호르몬(human chorionic gonadotropin, hCG; Chorulon, Intervet, UK)을 주사하였다. hCG 주사 14시간 후에 경추탈구로 안락사하고, 중기II(metaphase II) 난자를 체외수정 배지에서 채취하였다.All animal experiments were performed in compliance with the NIH Guide for the Care and Use of Research Animals. The animal study was approved by the Animal Experiment Ethics Committee of the Maria Medical Foundation Fertility Research Institute. As an elderly mouse model, 62-week-old B6D2 F1 (C57BL/6×DBA) female mice were used. 5 IU of gonadotropin was administered to female mice, and 48 hours after intraperitoneal injection of pregnant horse serum gonadotropin (PMSG; Folligon, Intervet, UK), human chorionic hormone was administered. (human chorionic gonadotropin, hCG; Chorulon, Intervet, UK) was injected. 14 hours after hCG injection, the animals were euthanized by cervical dislocation, and metaphase II eggs were collected from in vitro fertilization medium.

<1-2> 체외수정 및 체외배양<1-2> In vitro fertilization and in vitro culture

B6D2 F1 수컷의 부정소 미부(cauda epididymis)로부터 정자를 채취하였다. 그 다음, 상기 실시예 <1-1>에서 채취한 난자 각각을 MRC, MRC+Lipoic acid, MRC+Resveratrol, MRC+phosphate, MRC+Lipoic acid+Resveratrol 그룹으로 나누고, 수정을 실시하였다.Sperm were collected from the cauda epididymis of B6D2 F1 males. Next, each of the eggs collected in Example <1-1> was divided into MRC, MRC+Lipoic acid, MRC+Resveratrol, MRC+phosphate, and MRC+Lipoic acid+Resveratrol groups, and fertilization was performed.

구체적으로, MRC 그룹은 MRC#D01, MRC#D13, MRC#D46 배지를, MRC+Lipoic acid 그룹(비교군 1)은 상기 <비교예 1>에서 제조한 리포산이 첨가된 MRC#D01, MRC#D13, MRC#D46 배지를, MRC+Resveratrol 그룹(비교군 2)은 상기 <비교예 2>에서 제조한 레스베라트롤이 첨가된 MRC#D01, MRC#D13, MRC#D46 배지를, MRC+phosphate 그룹은 상기 <비교예 3>에서 제조한 인산염이 첨가된 MRC#D01, MRC#D13, MRC#D46 배지를 사용하여 수정 및 배양을 실시하였다. 기본 배지로 수정 시에는 MRC#D01 배지를 사용하였고, 수정 5시간 후 초기배 배양 시에는 MRC#D13을 사용하였으며, 후기배의 배양 시에는 MRC#D46 배지를 사용하였다. 또한, 두 단계 모두에서 배아는 미네랄 오일 하에서 배지 50μl 방울당 10개의 배아 그룹으로 배양하였다. Specifically, the MRC group received MRC#D01, MRC#D13, and MRC#D46 media, and the MRC+Lipoic acid group (comparative group 1) received MRC#D01 and MRC# to which the lipoic acid prepared in <Comparative Example 1> was added. D13 and MRC#D46 medium, the MRC+Resveratrol group (comparative group 2) used MRC#D01, MRC#D13 and MRC#D46 medium supplemented with resveratrol prepared in <Comparative Example 2>, and the MRC+phosphate group used Fertilization and culture were performed using MRC#D01, MRC#D13, and MRC#D46 media supplemented with phosphate prepared in <Comparative Example 3>. As a basic medium, MRC#D01 medium was used when cultivating early embryos 5 hours after fertilization, MRC#D13 medium was used, and MRC#D46 medium was used when cultivating late embryos. Additionally, embryos in both stages were cultured in groups of 10 embryos per 50 μl drop of medium under mineral oil.

한편, 수정 후 배양하는 동안 광학현미경 하에서 배아 할구세포의 균등성(blastomere regularity), 파편화(blastomere fragmentation) 및 세포질의 과립화(cytoplasmic granularity)를 관찰하여 배아의 질을 평가하고 기록함으로써, 배아의 분열 및 배반포로의 발달 능력을 확인하였다.Meanwhile, during culture after fertilization, the quality of the embryo is evaluated and recorded by observing the blastomere regularity, blastomere fragmentation, and cytoplasmic granularity of embryonic blastomere cells under an optical microscope, thereby ensuring the division and The ability to develop into a blastocyst was confirmed.

GroupGroup No. of
Zygotes
No. of
Zygotes
No. of
2-cells
No. of
2-cells
No. of
4-cells <
No. of
4-cells <
No.(%) of embryos on D4No.(%) of embryos on D4
TBRTBR HdBHdB HgBHgB EdBEdB Deg-Deg- MRCMRC 9191 83
(91.2)
83
(91.2)
80
(96.4)
80
(96.4)
64
(77.1)
64
(77.1)
1
(1.2)
One
(1.2)
43
(51.8)
43
(51.8)
20
(24.1)
20
(24.1)
17
(20.5)
17
(20.5)
MRC+Lipoic acidMRC+Lipoic acid 8989 83
(93.3)
83
(93.3)
79
(95.2)
79
(95.2)
65
(78.3)
65
(78.3)
2
(2.4)
2
(2.4)
49
(59.0)
49
(59.0)
14
(16.9)
14
(16.9)
17
(20.5)
17
(20.5)
MRC+ResveratrolMRC+Resveratrol 6666 62
(93.9)
62
(93.9)
62
(100.0)
62
(100.0)
51
(82.3)
51
(82.3)
0
(0.0)
0
(0.0)
38
(61.3)
38
(61.3)
13
(21.0)
13
(21.0)
11
(17.7)
11
(17.7)
MRC+Lipoic acid+ResveratrolMRC+Lipoic acid+Resveratrol 8787 85
(97.7)
85
(97.7)
84
(98.8)
84
(98.8)
76
(89.4)
76
(89.4)
1
(1.2)
One
(1.2)
62
(72.9)
62
(72.9)
13
(15.3)
13
(15.3)
9
(10.6)
9
(10.6)
*TBR: 총 배반포 비율(Total Blastocyst rate) / HdB: 배반포가 나온 상황(Hatched blastocyst) / HgB: 배반포가 나오는 중(Hatching blastocyst) / EdB: 확장된 배반포(Expended blastocyst) / Deg-: 퇴화(degeneration)*TBR: Total Blastocyst rate / HdB: Hatched blastocyst / HgB: Hatching blastocyst / EdB: Expanded blastocyst / Deg-: Degeneration )

GroupGroup No. of
MII
No. of
MII
No. of
2-cells
No. of
2-cells
No. of
4-cells <
No. of
4-cells <
No.(%) of embryos on D4No.(%) of embryos on D4
TBRTBR >HgB>HgB EdBEdB Deg-Deg- MRCMRC 121121 115
(95.0)
115
(95.0)
115
(100.0)
115
(100.0)
107
(93.0)
107
(93.0)
64
(55.7)
64
(55.7)
43
(37.4)
43
(37.4)
8
(7.0)
8
(7.0)
MRC+PhosphateMRC+Phosphate 217217 211
(97.2)
211
(97.2)
210
(99.5)
210
(99.5)
200
(94.8)
200
(94.8)
160
(75.8)
160
(75.8)
40
(19.0)
40
(19.0)
11
(5.2)
11
(5.2)

그 결과, 표 2 및 표 3에 나타낸 바와 같이, 수정 후 배양 4일째 배아의 부화율(hatching rate)이 MRC+Lipoic acid+Resveratrol 그룹(74.1%, 표 2의 HdB 및 HgB 합)에서 MRC 그룹(53.0%) 대비 현저히 증가하였다. 또한, 수정 후 배양 4일째 배반포 비율도 MRC+Lipoic acid+Resveratrol 그룹(89.4%)이 MRC 그룹(77.1%) 대비 현저히 증가하였다. 한편, MRC 그룹(77.1%) 대비 MRC+Lipoic acid 그룹의 배반포 비율(78.3%) 증가 효과는 미미한 것으로 나타났다. MRC+Phosphate 그룹의 부화율 및 배반포 비율은 각각 75.8%, 94.8%로, MRC 그룹 대비 부화율 증가 효과는 우수하나, 배반포 비율 증가 효과는 다소 미미한 것으로 나타났다.As a result, as shown in Tables 2 and 3, the hatching rate of embryos on the 4th day of culture after fertilization was lower than that in the MRC+Lipoic acid+Resveratrol group (74.1%, sum of HdB and HgB in Table 2) and the MRC group (53.0%). %) increased significantly. In addition, the blastocyst rate on the 4th day of culture after fertilization was significantly increased in the MRC+Lipoic acid+Resveratrol group (89.4%) compared to the MRC group (77.1%). Meanwhile, the effect of increasing the blastocyst ratio (78.3%) in the MRC+Lipoic acid group compared to the MRC group (77.1%) was found to be minimal. The hatching rate and blastocyst rate of the MRC+Phosphate group were 75.8% and 94.8%, respectively. Although the effect of increasing the hatching rate was superior to that of the MRC group, the effect of increasing the blastocyst rate was somewhat insignificant.

<실험예 2> 체외수정 및 체외배양 시 리포산, 레스베라트롤 및 인산염 처리가 고령 난임 환자의 배아에 미치는 영향 확인<Experimental Example 2> Confirmation of the effects of lipoic acid, resveratrol, and phosphate treatment on embryos of elderly infertility patients during in vitro fertilization and in vitro culture

본 발명의 체외수정 및 체외배양 배지가 임상에서 노화된 난자 체외수정 및 체외배양에 적합한지 알아보기 위하여, 고령 난임 환자의 난자를 상기 <실시예 2>에서 제조한 체외수정 및 체외배양 배지를 이용하여 체외수정 및 체외배양한 후 배아를 확인하였다.In order to determine whether the in vitro fertilization and in vitro culture medium of the present invention is suitable for in vitro fertilization and in vitro culture of aged eggs in clinical practice, eggs from elderly infertility patients were used using the in vitro fertilization and in vitro culture medium prepared in <Example 2> above. After in vitro fertilization and in vitro culture, the embryos were confirmed.

<2-1> 난자 준비<2-1> Egg preparation

고령 난임 환자로부터 난자를 채취하였다.Eggs were collected from elderly infertile patients.

구체적으로, 시험관아기 전문센터인 마리아의료재단에서 2019년 1월부터 2021년 12월까지 40세 이상의 난임 환자 966명을 대상으로 월경주기 제2~3일부터 난포자극호르몬(follicle stimulating hormone, FSH)과 사람의 폐경기성선자극호르몬(human menopausal gonadotropin, HMG)을 성선자극호르몬 방출호르몬(gonadotropin releasing hormone, GnRH)의 유사체 (agonist) 혹은 길항체(antagonist)와 함께 투여하여 과배란을 유도하고 사람의 융모막호르몬(human chorionic gonadotropin, HCG)을 투여한 후에 질식초음파를 이용하여 난자를 채취하였다.Specifically, from January 2019 to December 2021, the Maria Medical Foundation, a specialized center for in vitro fertilization, administered follicle stimulating hormone (FSH) to 966 infertile patients aged 40 or older from the 2nd to 3rd day of their menstrual cycle. and human menopausal gonadotropin (HMG) is administered together with an agonist or antagonist of gonadotropin releasing hormone (GnRH) to induce superovulation, and human chorionic hormone After administering human chorionic gonadotropin (HCG), eggs were collected using transvaginal ultrasound.

<2-2> 정자의 준비<2-2> Preparation of sperm

부인으로부터 난자를 채취한 직후에 성숙한 난자들이 존재하면 남편의 정액을 채취하였다. 채취된 정액을 무균작업대에 놓고 30∼60분 동안 정액 내에 들어 있는 고형물질들의 액화를 유도하였다. 액화된 정액에 3ml의 정액처리용 배양액(MRC#SW)을 처리하여 희석하였다. 희석된 정액은 그 부피를 조사하고 정자의 농도, 생존율 및 운동성을 검사하였다. 그 다음, 300×g에서 5분간 원심분리하여 상층액을 제거하고 남은 정자괴에 MRC#SW를 첨가하여 300×g에서 10분간 원심분리하였다. 이후 상층액을 제거하고 남은 정자괴에 0.7ml의 정자 배양용 배양액(MRC-SC)을 조심스럽게 올리고 36.8℃의 온도와 5%의 CO2가 조절된 배양기에서 정자의 부유를 유도하였다. 2시간 후에 정자용액의 상층부위를 회수하고 수정을 유도하기 전까지 시험관에 넣어 빛이 없는 상온에 두었다.Immediately after collecting eggs from the wife, if mature eggs were present, the husband's semen was collected. The collected semen was placed on a sterile workbench and liquefaction of solid substances contained in the semen was induced for 30 to 60 minutes. The liquefied semen was treated with 3ml of culture medium for semen processing (MRC#SW) and diluted. The volume of the diluted semen was examined, and sperm concentration, survival rate, and motility were tested. Next, centrifugation was performed at 300 × g for 5 minutes to remove the supernatant. MRC#SW was added to the remaining sperm mass and centrifugation was performed at 300 × g for 10 minutes. After removing the supernatant, 0.7 ml of culture medium for sperm culture (MRC-SC) was carefully added to the remaining sperm mass, and floating of sperm was induced in an incubator controlled at a temperature of 36.8°C and 5% CO 2 . After 2 hours, the upper part of the sperm solution was recovered and placed in a test tube at room temperature without light until fertilization was induced.

<2-3> 수정 유도<2-3> Inducing correction

채취한 난자 각각을 MRC, MRC+Lipoic acid+Resveratrol+phosphate 그룹으로 나누고, 5시간 후 수정을 실시하였다.Each of the collected eggs was divided into MRC, MRC+Lipoic acid+Resveratrol+phosphate groups, and fertilization was performed 5 hours later.

구체적으로, MRC+Lipoic acid+Resveratrol+phosphate 그룹은 상기 <실시예 2>에서 제조한 리포산, 레스베라트롤 및 인산염이 첨가된 MRC#D01 배지 1ml에 상기 실험예 <2-1>에서 채취한 난자를 첨가하였다. 5시간 후 상기 난자가 들어있는 배지에 상기 실험예 <2-2>에서 준비한 정자를 1.0×105개로 주입하고 19시간 동안 6% CO2, 5% O2 및 89% N2로 분압이 조절되고 36.8℃로 온도가 조절된 배양기에 넣어 수정을 유도하였다.Specifically, the MRC+Lipoic acid+Resveratrol+phosphate group added the eggs collected in Experimental Example <2-1> to 1 ml of MRC#D01 medium containing lipoic acid, resveratrol, and phosphate prepared in <Example 2>. did. After 5 hours, 1.0 × 10 5 sperm prepared in Experimental Example <2-2> were injected into the medium containing the egg, and the partial pressure was adjusted to 6% CO 2 , 5% O 2 and 89% N 2 for 19 hours. and placed in an incubator with a temperature controlled at 36.8°C to induce fertilization.

또한, MRC 그룹(대조군)은 MRC#D01 배지를 사용하여 상기와 동일한 방법으로 수정을 유도하였다. In addition, the MRC group (control group) used MRC#D01 medium to induce fertilization in the same manner as above.

<2-4> 수정 확인 및 초기배의 배양<2-4> Confirmation of fertilization and culture of early embryos

상기 실험예 <2-3>에서 수정을 실시한 다음날 아침 난자에서 제2극체와 자웅전핵을 관찰함으로써 정상적인 수정여부를 판정하였다.The morning after fertilization in Experimental Example <2-3>, normal fertilization was determined by observing the second polar body and the hermaphroditic nucleus in the egg.

정상적인 수정이 확인된 MRC+Lipoic acid+Resveratrol+phosphate 그룹의 배아는 새로운 배양접시에 상기 <실시예 2>에서 제조한 리포산, 레스베라트롤 및 인산염이 첨가된 MRC#D13 배지로 10~50㎕의 미세소적을 만들어 그 안에 넣고, 6% CO2, 5% O2 및 89% N2로 분압이 조절되고 36.8℃로 온도가 조절된 배양기에 넣고 48시간 동안 배양하였다.Embryos of the MRC+Lipoic acid+Resveratrol+phosphate group, in which normal fertilization was confirmed, were placed in a new culture dish with 10-50 ㎕ microdroplets of MRC#D13 medium supplemented with lipoic acid, resveratrol, and phosphate prepared in <Example 2>. was made and placed therein, placed in an incubator where the partial pressure was adjusted to 6% CO 2 , 5% O 2 , and 89% N 2 and the temperature was adjusted to 36.8°C, and cultured for 48 hours.

또한, MRC 그룹은 MRC#D13 배지를 사용하여 상기와 동일한 방법으로 배양하였다.Additionally, the MRC group was cultured in the same manner as above using MRC#D13 medium.

수정 후 배양 3일째 배아는 광학현미경 하에서 할구세포의 균등성, 파편화 및 세포질의 과립화를 관찰하여 배아의 질을 평가하였다. 그 다음, 수정 후 배양 3일째 배아 중 가장 양호한 배아들을 이식하였다.On the 3rd day of culture after fertilization, embryo quality was evaluated by observing blastomere cell uniformity, fragmentation, and cytoplasmic granulation under a light microscope. Next, the best embryos among the embryos on the third day of culture after fertilization were transferred.

<2-5> 후기배의 배양 및 이식<2-5> Culture and transplantation of late embryos

상기 실험예 <2-4>의 남은 배아는 MRC+Lipoic acid+Resveratrol+phosphate 그룹의 경우 새로운 배양접시에 상기 <실시예 2>에서 제조한 리포산, 레스베라트롤 및 인산염이 첨가된 MRC#D46 배지로 10~50㎕의 미세소적을 만들어 그 안에 넣고, 6% CO2, 5% O2 및 89% N2로 분압이 조절되고 36.8℃로 온도가 조절된 배양기에 넣고 48시간 동안 배양하였다. MRC 그룹은 MRC#D46 배지를 사용하여 상기와 동일한 방법으로 배양하였다.The remaining embryos of Experimental Example <2-4>, in the case of the MRC+Lipoic acid+Resveratrol+phosphate group, were cultured in a new culture dish with MRC#D46 medium supplemented with lipoic acid, resveratrol, and phosphate prepared in <Example 2> for 10 days. ~50㎕ of microdroplets were made and placed in an incubator where the partial pressure was adjusted to 6% CO 2 , 5% O 2 and 89% N 2 and the temperature was adjusted to 36.8°C and cultured for 48 hours. The MRC group was cultured in the same manner as above using MRC#D46 medium.

수정 후 배양 5일째 배아를 이식할 경우 상기와 같이 배아의 질을 평가하고, 가장 양호한 배아들을 이식하였다. 이식 후 착상률 및 임신률을 평가하였다.When embryos were transferred on the fifth day of culture after fertilization, the quality of the embryos was evaluated as above, and the best embryos were transferred. Implantation and pregnancy rates were evaluated after transplantation.

GroupGroup p-valuep-value MRC+Lipoic acid+Resveratrol+phosphateMRC+Lipoic acid+Resveratrol+phosphate MRCMRC No. of patientsNo. of patients 502502 464464 Age(yr)±SD Age(yr)±SD 42.5±2.242.5±2.2 42.3±2.0 42.3±2.0 0.3580.358 No. of previous ART cycles±SDNo. of previous ART cycles±SD 3.6±2.33.6±2.3 3.7±2.53.7±2.5 0.6800.680 Thickness of endometrium±SDThickness of endometrium±SD 9.2±1.59.2±1.5 9.4±1.4 9.4±1.4 0.3120.312 Maturation rate per oocytes(%)Maturation rate per oocytes(%) 74.6 74.6 75.875.8 0.2900.290 Fertilization rate(%) Fertilization rate(%) 81.881.8 8080 0.1650.165 No. of transferred embryos±SDNo. of transferred embryos±SD 2.4±0.62.4±0.6 2.4±0.6 2.4±0.6 0.8180.818 Good quality embryo rate(%) Good quality embryo rate(%) 44.044.0 36.436.4 0.050.05 Pregnancy rate(%) Pregnancy rate(%) 26.826.8 22.722.7 0.1670.167 Implantation rate(%) Implantation rate(%) 11.911.9 9.99.9 0.1310.131

그 결과, 표 4에 나타낸 바와 같이, MRC 그룹 대비 MRC+Lipoic acid+Resveratrol+phosphate 그룹에서 배아의 질이 향상되고, 임신률 및 착상률이 증가하는 것을 확인하였다.As a result, as shown in Table 4, it was confirmed that the quality of embryos was improved and the pregnancy rate and implantation rate were increased in the MRC+Lipoic acid+Resveratrol+phosphate group compared to the MRC group.

상기의 결과를 통해 리포산 및 레스베라트롤을 포함하는 배지 및 추가로 인산염을 포함하는 배지를 노화된 난자 체외수정 및 체외배양에 이용하면, 배아의 분열 및 배반포 형성률이 증가하고, 배아의 질이 향상되어 임신률 및 착상률이 증가하는 것을 확인하였으므로, 상기 배지는 노화된 난자 체외수정 및 체외배양에 적합함을 알 수 있다.Based on the above results, when the medium containing lipoic acid and resveratrol and the medium containing phosphate are used for in vitro fertilization and in vitro culture of aged eggs, the rate of embryo division and blastocyst formation increases, and the quality of the embryo improves, leading to pregnancy. Since it was confirmed that the rate and implantation rate increased, it can be seen that the medium is suitable for in vitro fertilization and in vitro culture of aged eggs.

Claims (7)

리포산(lipoic acid), 레스베라트롤(resveratrol) 및 인산염을 유효성분으로 포함하는, 포유동물의 난자 및 정자 체외수정 및 체외배양용 배지 조성물로서,
상기 난자는 노화된 난자인 배지 조성물.
A medium composition for in vitro fertilization and in vitro culture of mammalian eggs and sperm containing lipoic acid, resveratrol and phosphate as active ingredients,
A medium composition in which the egg is an aged egg.
제1항에 있어서, 상기 배지 조성물은 0.1 내지 2 μM의 리포산을 포함하는 것인 배지 조성물.
The medium composition according to claim 1, wherein the medium composition contains 0.1 to 2 μM lipoic acid.
제1항에 있어서, 상기 배지 조성물은 0.1 내지 1 μM의 레스베라트롤을 포함하는 것인 배지 조성물.
The medium composition according to claim 1, wherein the medium composition contains 0.1 to 1 μM of resveratrol.
삭제delete 제1항에 있어서, 상기 배지 조성물은 0.1 내지 1 mM의 인산염을 추가로 포함하는 것인 배지 조성물.
The medium composition according to claim 1, wherein the medium composition further contains 0.1 to 1 mM phosphate.
삭제delete 제1항에 있어서, 상기 배지 조성물은 체외배양 배지에 첨가되는 것인 배지 조성물.The medium composition according to claim 1, wherein the medium composition is added to an in vitro culture medium.
KR1020230165561A 2023-11-24 2023-11-24 Composition of in vitro fertilization and in vitro culture medium for aged oocyte containing lipoic acid and resveratrol KR102654800B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020230165561A KR102654800B1 (en) 2023-11-24 2023-11-24 Composition of in vitro fertilization and in vitro culture medium for aged oocyte containing lipoic acid and resveratrol

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020230165561A KR102654800B1 (en) 2023-11-24 2023-11-24 Composition of in vitro fertilization and in vitro culture medium for aged oocyte containing lipoic acid and resveratrol

Publications (1)

Publication Number Publication Date
KR102654800B1 true KR102654800B1 (en) 2024-04-03

Family

ID=90662339

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020230165561A KR102654800B1 (en) 2023-11-24 2023-11-24 Composition of in vitro fertilization and in vitro culture medium for aged oocyte containing lipoic acid and resveratrol

Country Status (1)

Country Link
KR (1) KR102654800B1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190089782A (en) * 2018-01-23 2019-07-31 차의과학대학교 산학협력단 Composition and Method for enhancing developmental rate of embryos using melatonin
KR102054710B1 (en) 2018-04-24 2019-12-11 전북대학교 산학협력단 Medium composition for in vitro fertilization comprising granule from Acer mono sap as effective component and method of in vitro fertilization using the same
US20220183271A1 (en) * 2019-03-13 2022-06-16 Membrane Protective Technologies, Inc. Methods and Systems for Protective Supplementation During Temperature Depression
KR102469369B1 (en) 2022-03-17 2022-11-18 충북대학교 산학협력단 Medium composition for in vitro culture of mammalian fertilized eggs containing interleukin 7

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190089782A (en) * 2018-01-23 2019-07-31 차의과학대학교 산학협력단 Composition and Method for enhancing developmental rate of embryos using melatonin
KR102054710B1 (en) 2018-04-24 2019-12-11 전북대학교 산학협력단 Medium composition for in vitro fertilization comprising granule from Acer mono sap as effective component and method of in vitro fertilization using the same
US20220183271A1 (en) * 2019-03-13 2022-06-16 Membrane Protective Technologies, Inc. Methods and Systems for Protective Supplementation During Temperature Depression
KR102469369B1 (en) 2022-03-17 2022-11-18 충북대학교 산학협력단 Medium composition for in vitro culture of mammalian fertilized eggs containing interleukin 7

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Antiinflamm Antiallergy Agents Med Chem. 2020;19(2):149-157. *
PNAS Nexus, Volume 2, Issue 2, February 2023, pgac310 *

Similar Documents

Publication Publication Date Title
Baldassarre et al. Advanced assisted reproduction technologies (ART) in goats
Moore et al. Major advances associated with reproduction in dairy cattle
US11957384B2 (en) Method of producing a peripheral blood mononuclear cell composition suitable for repairing or engineering a tissue
Sankai et al. Cryopreservation of spermatozoa from cynomolgus monkeys (Macaca fascicularis)
Thongphakdee et al. The impact of ovarian stimulation protocol on oocyte quality, subsequent in vitro embryo development, and pregnancy after transfer to recipients in Eld's deer (Rucervus eldii thamin)
Dal Canto et al. IVM–the first choice for IVF in Italy
KR102654800B1 (en) Composition of in vitro fertilization and in vitro culture medium for aged oocyte containing lipoic acid and resveratrol
Faerge et al. The effect of FF-MAS on porcine cumulus–oocyte complex maturation, fertilization and pronucleus formation in vitro
Lin et al. The effects of brief gamete co-incubation in human in vitro fertilization
Caillaud et al. In vitro equine oocyte maturation in pure follicular fluid plus interleukin-1 and fertilization following ICSI
Misra et al. Embryo transfer technology (ETT) in cattle and buffalo in India: A review
KR102183228B1 (en) Composition for in vitro oocyte maturation and early embryonic development comprising Mito-TEMPO and culture method using the same
CN112899220B (en) HTF liquid drop for improving fertilization capacity of mouse sperm and preparation and use methods thereof
Fair et al. Developments in the use of embryo technologies in dairy cows
Yadav et al. Effect of oviductal cell co-culture on cleavage and development of buffalo IVF embryos
US9890356B2 (en) Use of G-CSF in in vitro embryo culture
Malik et al. Peritoneal fluid from rabbits or goats as media for in vitro maturation, fertilization and initial culture of caprine oocytes
Matsunaga et al. Effect of melatonin on developmental competence of denuded human oocytes during in vitro maturation
Abdulkadim Advantage of day 3 over day 2 embryo transfer.
Thiangthientham et al. Ovarian stimulation with a low dose of follicle stimulating hormone improved recovery rates and developmental competence of goat oocytes
López-Gatius Negative photoperiod induces an increase in the number of ovulations in dairy cattle
Sakellariou et al. Intravenous infusion of PAF affects ovulation, fertilization and preimplantation embryonic development in NZB x NZW F1 hybrid mice
CN111593020A (en) Culture solution and culture method for bovine in-vitro fertilized embryo or bovine cloned embryo
CN115651894A (en) Application of HNG in preparation for promoting maturation of human oocyte
JP2021136891A (en) Liquid composition for microinsemination, liquid composition for activating unfertilized egg, fertilized egg and embryo, method for microinsemination using the same, and method for activating unfertilized egg, fertilized egg and embryo

Legal Events

Date Code Title Description
GRNT Written decision to grant